Gustave Roussy Immune Score Is a Prognostic Factor for Chemotherapy-Naive Pulmonary Adenocarcinoma With Wild-Type Epidermal Growth Factor Receptor

BACKGROUND: The Gustave Roussy Immune Score (GRIm-Score) was developed based on the Royal Marsden Hospital (RMH) prognostic score for the purpose of a better patient selection for immunotherapy phase I trials. This scoring system is simply calculated by neutrophil-to-lymphocyte ratio, lactate dehydr...

Descripción completa

Detalles Bibliográficos
Autores principales: Minami, Seigo, Ihara, Shouichi, Komuta, Kiyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396777/
https://www.ncbi.nlm.nih.gov/pubmed/30834052
http://dx.doi.org/10.14740/wjon1184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396777/
https://www.ncbi.nlm.nih.gov/pubmed/30834052
http://dx.doi.org/10.14740/wjon1184

Ejemplares similares